CCTC KIDNEY TRANSPLANT 2026
IMMUNOSUPPRESSIVE THERAPY DRUG
REGIMENS MONITORING AND SAFETY
PROTOCOLS REVIEW
◉ General Laboratory Testing includes...
Answer: Basic metabolic panel
Hepatic panel
Lipid profile
Complete blood count
Thyroid panel
Urinalysis
ABO Coagulation
◉ PRA is determined by...
, Answer: testing the serum of prospective recipient against a panel of
lymphocytes for the presence of circulating antibodies reactive
against HLA antigens
◉ PRA is expressed as a...
Answer: percentage between 0 and 100%
◉ PRA represents...
Answer: the % of the population against which the recipient will
have pre-formed antibodies
◉ The higher the PRA %, the ...
Answer: harder it is to find a good match for transplant
◉ Human Leukocyte Antigen (HLA) is...
Answer: assessed pre-operatively in the allocation of kidneys
used in certain organs to predict rejection
signifies that rejection may happen when the recipient has
antibodies to the donor's antigens
◉ Infection screening determines...
Answer: the recipient's suitability for transplant and post-transplant
infection risk
IMMUNOSUPPRESSIVE THERAPY DRUG
REGIMENS MONITORING AND SAFETY
PROTOCOLS REVIEW
◉ General Laboratory Testing includes...
Answer: Basic metabolic panel
Hepatic panel
Lipid profile
Complete blood count
Thyroid panel
Urinalysis
ABO Coagulation
◉ PRA is determined by...
, Answer: testing the serum of prospective recipient against a panel of
lymphocytes for the presence of circulating antibodies reactive
against HLA antigens
◉ PRA is expressed as a...
Answer: percentage between 0 and 100%
◉ PRA represents...
Answer: the % of the population against which the recipient will
have pre-formed antibodies
◉ The higher the PRA %, the ...
Answer: harder it is to find a good match for transplant
◉ Human Leukocyte Antigen (HLA) is...
Answer: assessed pre-operatively in the allocation of kidneys
used in certain organs to predict rejection
signifies that rejection may happen when the recipient has
antibodies to the donor's antigens
◉ Infection screening determines...
Answer: the recipient's suitability for transplant and post-transplant
infection risk